Amgen Inc logo

Amgen Inc

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. Its products include Aranesp to treat anemia; Neulasta to treat neutropenia; EPOGEN and Procrit to treat anemia; Sensipar/Mimpara to treat secondary hyperparalytic and hypercalcemia; Xgeva for skeletal-related events prevention; Vectibix to treat colorectal cancer; NEUPOGEN to stimulate production of white blood cells in cancer patients undergoing chemotherapy; and ENBREL a tumor necrosis factor blocker to treat rheumatoid arthritis polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis diseases or conditions.

Latest events on Quartr

Previous Events for Amgen Inc

Ticker

AMGN

Country

United States of America

About the company

https://www.amgen.com

Investor Relations page

https://investors.amgen.com

Dig deeper into the fundamentals using Quartr - Investor relations

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
Android play link
App store link
Quartr app screenshot